Short Interest in Poxel S.A. (OTCMKTS:PXXLF) Grows By 9,300.0%

Poxel S.A. (OTCMKTS:PXXLF) was the recipient of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 9,400 shares, an increase of 9,300.0% from the January 31st total of 100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Poxel Price Performance

PXXLF remained flat at $0.25 during trading on Thursday. The firm’s fifty day moving average price is $0.25 and its two-hundred day moving average price is $0.49. Poxel has a 12 month low of $0.25 and a 12 month high of $0.25.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.